Pacific Northwest Biotechnology
Pacific Northwest Biotechnology is a pharmaceuticals and biotechnology firm that provides designing and delivers therapeutic agents, develop novel peptide and peptidomimetic drugs, drug development, research and development, pharmaceuticals to treat cancer, cognitive dysfunction, fibrotic disease, and facilitate wound healing.
Industries
Nr. of Employees
small (1-50)
Pacific Northwest Biotechnology
Products
Angiotensin-Related Peptides and Peptidomimetics
Libraries of peptides and peptidomimetics targeting tissue remodeling and c-Met/HGF signaling for therapeutic use in cancer, neurodegenerative, fibrotic diseases, and wound healing.
Anti-Cancer Therapeutic Compounds
Lead compounds that inhibit c-Met signaling to reduce tumor growth, metastasis, and angiogenesis in various cancer models.
Pro-Cognitive Therapeutic Molecules
Molecules that enhance cognitive function and reverse memory deficits in dementia models, including blood-brain barrier permeant compounds.
Wound Healing Therapeutic Compounds
Lead compounds that accelerate dermal wound closure and improve wound strength through various administration routes.
Angiotensin-Related Peptides and Peptidomimetics
Libraries of peptides and peptidomimetics targeting tissue remodeling and c-Met/HGF signaling for therapeutic use in cancer, neurodegenerative, fibrotic diseases, and wound healing.
Anti-Cancer Therapeutic Compounds
Lead compounds that inhibit c-Met signaling to reduce tumor growth, metastasis, and angiogenesis in various cancer models.
Pro-Cognitive Therapeutic Molecules
Molecules that enhance cognitive function and reverse memory deficits in dementia models, including blood-brain barrier permeant compounds.
Wound Healing Therapeutic Compounds
Lead compounds that accelerate dermal wound closure and improve wound strength through various administration routes.